Renal clearance and daily excretion of cortisol and adrenal androgens in patients with rheumatoid arthritis and systemic lupus erythematosus

Annals of the Rheumatic Diseases

Volumn 63, Issue 8, 2004, Pages 961-968

  Straub, R H ^a   Weidler, C ^a   Demmel, B ^a   Herrmann, M ^b   Kees, F ^c   Schmidt, M ^d   Scholmerich J ^a   Schedel, J ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c UNIVERSITY OF REGENSBURG   (Germany)

^d JENA UNIVERSITY HOSPITAL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTENEDIONE; AZATHIOPRINE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; HYDROXYPROGESTERONE; LEFLUNOMIDE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PRASTERONE; PRASTERONE SULFATE; PREDNISOLONE; SALAZOSULFAPYRIDINE;

ADRENAL GLAND; ADULT; ANDROGEN RELEASE; ARTICLE; CLEARANCE; CONTROLLED STUDY; FEMALE; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYDROCORTISONE RELEASE; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEINURIA; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

17-ALPHA-HYDROXYPROGESTERONE; ADRENAL CORTEX HORMONES; ADULT; ANDROSTENEDIONE; ARTHRITIS, RHEUMATOID; DEHYDROEPIANDROSTERONE; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; KIDNEY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; PROTEINURIA;

EID: 3242694146     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.014274     Document Type: Article

References (39)

1. Reincke M, Heppner C, Petzke F, Allolio B, Arlt W, Mbulamberi D, et al. Impairment of adrenocortical function associated with increased plasma tumor necrosis factor-alpha and interleukin-6 concentrations in African trypanosomiasis. Neuroimmunomodulation 1994;1:14-22.
2. Johnson EO, Vlachoyiannopoulos PG, Skopouli FN, Tzioufas AG, Moutsopoulos HM. Hypofunction of the stress axis in Sjögren's syndrome. J Rheumatol 1998;25:1508-14.
3. Zietz B, Reber T, Oertel M, Glück T, Schölmerich J, Straub RH. Altered function of the hypothalamic stress axes in patients with moderately active systemic lupus erymematosus. II. Dissociation between androstenedione, cortisol, or dehydroepiandrosterone and interleukin 6 or tumor necrosis factor. J Rheumatol 2000;77:911-18.
4. van den Brink HR, Blankenstein MA, Koppeschaar HP, Bijlsma JW. Influence of disease activity on steroid hormone levels in peripheral blood of patients with rheumatoid arthritis. Clin Exp Rheumatol 1993;11:649-52.
5. Hall J, Morand EF, Medbak S, Zaman M, Perry L, Goulding NJ, et al. Abnormal hypothalamic-pituitary-adrenal axis function in rheumatoid arthritis. Effects of nonsteroidal antiinflammatory drugs and water immersion. Arthritis Rheum 1994;37:1132-7.
6. Gudbjornsson B, Skogseid B, Oberg K, Wide L, Hallgren R. Intact adrenocorticotropic hormone secretion but impaired cortisol response in patients with active rheumatoid arthritis. Effect of glucocorticoids. J Rheumatol 1996;23:596-602.
7. Templ E, Koeller M, Riedl M, Wagner O, Graninger W, Luger A. Anterior pituitary function in patients with newly diagnosed rheumatoid arthritis. Br J Rheumatol 1996;35:350-6.
8. Crofford U, Kalogeras KT, Mastorakos G, Magiakou MA, Wells J, Kanik KS, et al. Orcadian relationships between interleukin (IL)-6 and hypothalamic-pituitary-adrenal axis hormones: failure of IL-6 to cause sustained hypercortisolism in patients with early untreated rheumatoid arthritis. J Clin Endocrinol Metab 1997;82:1279-83.
9. Cutolo M, Foppiani L, Prete C, Ballarino P, Sulli A, Villaggio B, et al. Hypothalamic-pituitary-adrenocortical axis function in premenopausal women with rheumatoid arthritis not treated with glucocorticoids. J Rheumatol 1999;26:282-8.
10. Gutierrez MA, Garcia ME, Rodriguez JA, Mardonez G, Jacobelli S, Rivero S. Hypothalamic-pituitary-adrenal axis function in patients with active rheumatoid arthritis: a controlled study using insulin hypoglycemia stress test and prolactin stimulation. J Rheumatol 1999;26:277-81.
11. Demir H, Kelestimur F, Tunc M, Kirnap M, Ozugul Y. Hypothalamo-pituitary- adrenal axis and growth hormone axis in patients with rheumatoid arthritis. Scand J Rheumatol 1999;28:41-6.
12. Kanik KS, Chrousos GP, Schumacher HR, Crane ML, Yarboro CH, Wilder RL. Adrenocorticotropin, glucocorticoid, and androgen secretion in patients with new onset synovitis/rheumatoid arthritis: relations with indices of inflammation. J Clin Endocrinol Metab 2000;85:1461-6.
13. Straub RH, Paimela L, Peltomaa R, Schölmerich J, Leirisalo-Repo M. Inadequately low serum levels of steroid hormones in relation to IL-6 and TNF in untreated patients with early rheumatoid arthritis and reactive arthritis. Arthritis Rheum 2002;46:654-62.
14. Feher GK, Feher T, Zahumenszky Z. Study on the inactivation mechanism of androgens in rheumatoid arthritis: excretory rate of free and conjugated 17-ketosteroids. Endokrinologie 1979;73:167-72.
15. Masi AT, Josipovic DB, Jefferson WE. Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis (RA): gas-liquid chromatographic studies of RA patients and matched normal control women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 1984;14:1-23.
16. Cutolo M, Balleari E, Giusti M, Monachesi M, Accorda S. Sex hormone status of male patients with rheumatoid arthritis: evidence of low serum concentrations of testosterone at baseline and after human chorionic gonadotropin stimulation. Arthritis Rheum 1988;31:1314-17.
17. Sambrook PN, Eisman JA, Champion GD, Pocock NA. Sex hormone status and osteoporosis in pastmenopausal women with rheumatoid arthritis. Arthritis Rheum 1988;31:973-8.
18. Deighlon CM, Watson MJ, Walker DJ. Sex hormones in postmenopausal HLA-identical rheumatoid arthritis discordant sibling pairs. J Rheumatol 1992;19:1663-7.
19. Hedman M, Nilsson E, de la Torre B. Low blood and synovial fluid levels of sulpho-conjugated steroids in rheumatoid arthritis. Clin Exp Rheumatol 1992;10:25-30.
20. Valentino R, Savastano S, Tommaselli AP, Riccio A, Mariniello P, Pronesti G, et al. Hormonal pattern in women affected by rheumatoid arthritis. J Endocrinol Invest 1993;16:619-24.
21. Mateo L, Nolla JM, Bonnin MR, Navarro MA, Roig-Escofet D. Sex hormone status and bone mineral density in men with rheumatoid arthritis. J Rheumatol 1995;22:1455-60.
22. Mirone L, Altomonte L, D'Agostino P, Zoli A, Barini A, Magaro M. A study of serum androgen and cortisol levels in female patients with rheumatoid arthritis. Correlation with disease activity. Clin Rheumatol 1996;15:15-19.
23. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001;44:493-507.
24. van Vollenhoven RF, Engleman EG, McGuire JL. Dehydroepiandrosterone in systemic lupus erythematosus. Results of a double-blind, placebo-controlled, randomized clinical trial. Arthritis Rheum 1995;38:1826-31.
25. Chang DM, Lan JL, Lin HY, Luo SF. Dehydroepiandrosterone treatment of women with mild-to-moderate systemic lupus erythematosus: a multicenter randomized, double-blind, placebo-controlled trial. Arthritis Rheum 2002;46:2924-7.
26. Petri MA, Lahita RG, van Vollenhoven RF, Merrill JT, Schiff M, Ginzler EM, et al. Effects of prasterone on corticosteroid requirements of women with systemic lupus erythematosus: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2002;46:1820-9.
27. Andus T, Klebl F, Rogler G, Bregenzer N, Schölmerich J, Straub RH. Patients with refractory Crohn's disease or ulcerative colitis respond to dehydroepiandrosterone: a pilot study. Aliment Pharmacol Ther 2003;17:409-14.
28. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
29. Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
30. Straub RH, Konecna L, Hrach S, Rothe G, Kreutz M, Schölmerich J, et al. Serum dehydroepiandrosterone (DHEA) and DHEA sulfate are negatively correlated with serum interleukin-6 (IL-6), and DHEA inhibits IL-6 secretion from mononuclear cells in man in vitro: passible link between endocrinosenescence and immunosenescence. J Clin Endocrinol Metab 1998;83:2012-17.
31. Ligthart GJ, Corberand JX, Fournier C, Galanaud P, Hijmans W, Kennes B, et al. Admission criteria for immunogerontological studies in man: the SENIEUR protocol. Mech Ageing Dev 1984;28:47-55.
32. Solorte SB, Severgnini S, Locatelli M, Cerutti N, Rondanelli M, Netti MA, et al. Nephelometry in the clinical assessment of glomerular proteinuria and tubular function in diabetic nephropathy. Clin Nephrol 1997;48:151-8.
33. Santos-Montes A, Gonzala-Lumbreras R, Izquierdo-Hornillos R. Simultaneous determination of cortisol and cortisone in urine by reversed-phase high-performance liquid chromatography. Clinical and doping control applications. J Chromatogr B Biomed Appl 1995;673:27-33.
34. Rovensky J, Imrich R, Koska J, Kovalancik M, Killinger Z, Payer J, et al. Cortisol elimimation from plasma in premenopausal women with rheumatoid arthritis. Ann Rheum Dis 2003;62:674-6.
35. Greenspan FS. Basic and clinical endocrinology. East Norwalk: Appleton and Lange, 1991.
36. Castagnetta LA, Carruba G, Granata OM, Stefano R, Miele M, Schmidt M, et al. Increased estrogen formation and estrogen to androgen ratio in the synovial fluid of patients with rheumatoid arthritis. J Rheumatol 2003;30:2597-605.
37. Jäättelä M, Ilvesmaki V, Voutilainen R, Stenman UH, Saksela E. Tumor necrosis factor as a patent inhibitor of adrenocorticotropin- induced cortisol production and steroidogenic P450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991;128:623-9.
38. Judd AM, Call GB, Barney M, McIlmoil CJ, Balls AG, Adams A, et al. Possible function of IL-6 and TNF as intraadrenal factors in the regulation of adrenal steroid secretion. Ann N Y Acad Sci 2000;917:628-37.
39. Straub RH, Pongratz G, Schölmerich J, Kees F, Schaible TF, Antoni C, et al. Long-term anti-tumor necrosis factor antibody therapy in rheumatoid arthritis patients sensitizes the pituitary gland and favors adrenal androgen secretion. Arthritis Rheum 2003;48:1504-12.